NYSE:TEVA
Teva Pharmaceutical (TEVA)
Financials 
Technical Analysis 
Jun 24, 2026, 12:00 amThis summary was created by AI, based on 3 opinions in the last 12 months.
Teva Pharmaceutical, represented by the symbol TEVA-N, is currently experiencing a robust demand for GLP (glucose-lowering agents), although the entry of more generics may lead to price declines in this sector. The company has shown a remarkable recovery under its current CEO, boasting a 264% increase since January 2023, suggesting it's on a promising turnaround. Its headquarters are located in Israel, and it holds a strong position as a large-cap pharmaceutical company, ranking #1 in its ADR/CDR universe among international stocks. Following a breakout over $21 in September, Teva has seen significant accumulation over the past six months, although it does not pay dividends. Analysts remain optimistic, with a price target of $34.50.
HQ is in Israel. Large-cap pharma. Right now, #1-ranked in his ADR/CDR universe (international stocks with American/Canadian Depositary Receipts). We've seen rotation into drug stocks. Broke out over $21 in September and has kept right on going. Very strong accumulation for about 6 months now. No dividend.
(Analysts’ price target is $34.50)
Colin Cieszynski
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Teva Pharmaceutical (TEVA) Frequently Asked Questions
What is Teva Pharmaceutical stock symbol?
Teva Pharmaceutical is a American stock, trading under the symbol TEVA (previously TEVA-N on Stockchase) on the New York Stock Exchange (TEVA). It is usually referred to as NYSE:TEVA or TEVA
Is Teva Pharmaceutical a buy or a sell?
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on TEVA (previously TEVA-N on Stockchase). 2 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Teva Pharmaceutical.
Is Teva Pharmaceutical a good investment or a top pick?
Teva Pharmaceutical was recommended as a Top Pick by Norman Levine on 2019-07-03. Read the latest stock experts ratings for Teva Pharmaceutical.
Why is Teva Pharmaceutical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Teva Pharmaceutical.
Is Teva Pharmaceutical worth watching?
Teva Pharmaceutical is followed by 69 investors on Stockchase and is a trending stock that is worth watching.
What is Teva Pharmaceutical stock price?
On 2026-06-24, Teva Pharmaceutical (TEVA) stock closed at a price of $34.22.
'%20fill='%23FFB800'%3e%3cg%20id='filled-.-button'%20transform='translate(120.000000,%20413.999972)'%3e%3cpath%20d='M101.499729,2.82302245e-05%20C102.285413,-0.00432461793%20103.254164,0.496634241%20103.645655,1.25173399%20L103.712109,1.39623206%20L105.747863,6.45331817%20L111.028779,6.80428588%20C111.60867,6.84282525%20112.147242,7.1236355%20112.517275,7.58038413%20C113.223405,8.45199453%20113.142035,9.72214747%20112.357105,10.4940033%20L112.234099,10.6059323%20L108.072656,14.10894%20L109.356339,19.592529%20C109.472157,20.0872738%20109.394126,20.6085551%20109.13883,21.0455786%20C108.624329,21.9263208%20107.536956,22.2447485%20106.649713,21.8010736%20L106.511398,21.7246573%20L101.5,18.7715858%20L96.4886024,21.7246573%20C95.5790916,22.2767096%2094.4027498,21.9726757%2093.8611695,21.0455786%20C93.6058745,20.6085551%2093.5278433,20.0872738%2093.6436608,19.592529%20L94.9273443,14.10894%20L90.7659013,10.6059323%20C89.8680707,9.85015912%2089.7412886,8.49557505%2090.4827254,7.58038413%20C90.8527577,7.1236355%2091.39133,6.84282525%2091.9712215,6.80428588%20L97.2521374,6.45331817%20L99.2878908,1.39623206%20C99.6240254,0.561228427%20100.665516,-0.00460395016%20101.499729,2.82302245e-05%20Z'%20id='top-picks-.-icon-copy-7'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
'%3e%3cg%20id='filled-.-button'%20transform='translate(120.000000,%20413.999944)'%3e%3cg%20id='Group-8'%20transform='translate(90.000000,%200.000000)'%3e%3cpath%20d='M11.4997292,5.58581788e-05%20C12.2854126,-0.00429698998%2013.2541635,0.496661868%2013.6456551,1.25176162%20L13.7121092,1.39625969%20L15.7478626,6.4533458%20L21.0287785,6.8043135%20C21.60867,6.84285288%2022.1472423,7.12366313%2022.5172746,7.58041175%20C23.2234049,8.45202216%2023.142035,9.7221751%2022.3571045,10.4940309%20L22.2340987,10.60596%20L18.0726557,14.1089676%20L19.3563392,19.5925566%20C19.4721567,20.0873014%2019.3941255,20.6085828%2019.1388305,21.0456062%20C18.6243292,21.9263484%2017.5369557,22.2447761%2016.6497127,21.8011012%20L16.5113976,21.7246849%20L11.5,18.7716134%20L6.48860242,21.7246849%20C5.5790916,22.2767372%204.40274983,21.9727033%203.86116953,21.0456062%20C3.60587449,20.6085828%203.52784326,20.0873014%203.64366079,19.5925566%20L4.9273443,14.1089676%20L0.76590125,10.60596%20C-0.13192926,9.85018675%20-0.258711404,8.49560268%200.482725407,7.58041175%20C0.85275775,7.12366313%201.39132997,6.84285288%201.97122149,6.8043135%20L7.25213737,6.4533458%20L9.28789079,1.39625969%20C9.62402537,0.561256055%2010.6655161,-0.00457632221%2011.4997292,5.58581788e-05%20Z'%20id='top-picks-.-icon-copy-7'%20fill='%23FFB800'%3e%3c/path%3e%3cpath%20d='M11.4997292,2.77818228e-05%20C12.2854126,-0.00429698998%2013.2541635,0.496661868%2013.6456551,1.25176162%20L13.7121092,1.39625969%20L15.7478626,6.4533458%20L21.0287785,6.8043135%20C21.60867,6.84285288%2022.1472423,7.12366313%2022.5172746,7.58041175%20C23.2234049,8.45202216%2023.142035,9.7221751%2022.3571045,10.4940309%20L22.2340987,10.60596%20L18.0726557,14.1089676%20L19.3563392,19.5925566%20C19.4721567,20.0873014%2019.3941255,20.6085828%2019.1388305,21.0456062%20C18.6243292,21.9263484%2017.5369557,22.2447761%2016.6497127,21.8011012%20L16.5113976,21.7246849%20L11.5,18.7716134%20C11.4998195,6.25722299%2011.4997292,2.77818228e-05%2011.4997292,2.77818228e-05%20Z'%20id='top-picks-.-icon-copy-8'%20fill='%23EAEAEA'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
'%20fill='%23EAEAEA'%3e%3cg%20id='filled-.-button'%20transform='translate(120.000000,%20413.999972)'%3e%3cpath%20d='M131.499729,2.82302245e-05%20C132.285413,-0.00432461793%20133.254164,0.496634241%20133.645655,1.25173399%20L133.712109,1.39623206%20L135.747863,6.45331817%20L141.028779,6.80428588%20C141.60867,6.84282525%20142.147242,7.1236355%20142.517275,7.58038413%20C143.223405,8.45199453%20143.142035,9.72214747%20142.357105,10.4940033%20L142.234099,10.6059323%20L138.072656,14.10894%20L139.356339,19.592529%20C139.472157,20.0872738%20139.394126,20.6085551%20139.13883,21.0455786%20C138.624329,21.9263208%20137.536956,22.2447485%20136.649713,21.8010736%20L136.511398,21.7246573%20L131.5,18.7715858%20L126.488602,21.7246573%20C125.579092,22.2767096%20124.40275,21.9726757%20123.86117,21.0455786%20C123.605874,20.6085551%20123.527843,20.0872738%20123.643661,19.592529%20L124.927344,14.10894%20L120.765901,10.6059323%20C119.868071,9.85015912%20119.741289,8.49557505%20120.482725,7.58038413%20C120.852758,7.1236355%20121.39133,6.84282525%20121.971221,6.80428588%20L127.252137,6.45331817%20L129.287891,1.39623206%20C129.624025,0.561228427%20130.665516,-0.00460395016%20131.499729,2.82302245e-05%20Z'%20id='top-picks-.-icon-copy-8'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
The demand of GLP remains strong, but as more generics enter the market, the prices of the GLPs will go down. If you bet on Teva, you expects GLP demand to remain strong. GLP will come in pill shape, and there will be more amazing drug discoveries. However, Teva isn't a very innovative company. He avoids pharma; it's too hard to determine who will be a winner.